TheraRadar
← Back
Data updated: Mar 29, 2026

PPI-DAC

Pharmaceuticals
Generics

PPI-DAC is a generic drug manufacturer with 3 FDA-approved products.

2009
Since
3
Drugs
-
Trials
8
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

NICOTINE POLACRILEX 2026-02-05
Labeling
NICOTINE POLACRILEX 2025-07-17
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2025-05-20
Labeling
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2025-05-20
Labeling
NICOTINE POLACRILEX 2025-04-01
Manufacturing (CMC)
CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE 2024-09-10
NICOTINE POLACRILEX 2024-07-12
Manufacturing (CMC)
NICOTINE POLACRILEX 2024-04-30
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...